The fifth and final task force focused on the outpatient management of LVAD recipients. This involved evaluating the safety of a patient’s home. For instance, an uninterrupted supply of electricity to continuously power the device is critical (Class I, level of evidence C). The primary caregiver must be educated on how the device functions (Class I, level of evidence C). All patients who are able should be registered into cardiac rehabilitation after receiving an LVAD (Class I, level of evidence C). This task force provides medical management guidelines for LVAD recipients. For instance, anticoagulation must be continued and the INR should be within the range specified by the device manufacturer (Class I, level of evidence B). Aspirin 81-325
